Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.

ccfDNA-related BMs are frequently detected in ACC patients and represent a promising, minimally invasive tool to predict clinical outcome and complement surveillance imaging. Our findings will be validated in a larger cohort of ACCs with long-term follow-up.